Bill > HB820

This bill requires all health insurers in Hawaii, including Medicaid managed care programs, to cover continuous glucose monitors (CGMs) and related supplies for individuals diagnosed with diabetes, starting from January 1, 2026. A continuous glucose monitor is defined as an electronic device that measures glucose levels through a skin-applied sensor, providing real-time data for at least seven days. The bill aims to address healthcare disparities, particularly in rural areas where residents face higher risks of chronic health issues like diabetes. The coverage must include repair and replacement parts for CGMs and can be subject to the same copayment, deductible, and coinsurance provisions as other medical services. The legislation is motivated by evidence showing that CGMs help patients avoid dangerous blood sugar fluctuations, reduce long-term complications, and improve overall health outcomes. The Department of Human Services is authorized to seek federal waivers to implement the bill, and the departments of health and human services may accept external funding to support expanding CGM access. The bill will take effect on July 1, 2025, with the insurance coverage provisions applying to policies issued or renewed after December 31, 2025.

Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=820&year=2026